Vicodin is a prescription medicine that is a combination medicine for pain medication containing hydrocodone, which is an opioid, and acetaminophen. It is a discontinued drug, but a generic dosage is marketed. It is used to treat pain; acetaminophen is a less potent painkiller and is used to enhance the activity of hydrocodone, which is an opioid pain medication and is also a narcotic drug. It works by binding to mu-opioid receptors in the CNS, which helps block the pain signals, and the acetaminophen increases the pain-relieving effect. The brand Vicodin is discontinued, but generic hydrocodone/acetaminophen tablets remain widely available. There is a risk of overdose and death, as opioid addiction and misuse lead to death.
Important Warnings while taking Vicodin
It is advised not to consume the medicine without a prescription, as it can cause addiction and even lead to overdosing and can lead to problem in breathing. It is not allowed to share the medicine with other people having history of drug abuse and addiction. Due to these risks associated with hydrocodone and acetaminophen, such as potential fatal respiratory depression, overdose, addiction, and misuse, it is classified under schedule II substance.
It is expected to schedule the dose as prescribed and maintain the dose frequency for better results. Combining the medicine with other sedatives can increase the risk of dangerous breathing problems. If the patient is consuming alcohol, it is not advised to take pills, as it can trigger depression and can cause sedation, respiratory depression, coma, and death.
Liver injury is also associated with acetaminophen, which is a major concern; that is why it is advised to consume the recommended amount and not more than that, and use of several other medicines at the same time results in liver damage. Immediate medical help is advised if the patient notices skin redness and rash that causes blistering and peeling.
It is also seen that hydrocodone can cause neonatal opioid withdrawal syndrome when used in pregnancy, and prolonged use of opioids can lead to dependency, which is why it is advised not to discontinue the medicine without consultation.
Things to consider before Vicodin consumption
Before taking Vicodin, patients should tell their healthcare provider if they have:
- Allergies
- Breathing problems or asthma
- Liver disease
- Alcohol use
- History of substance use
- Head injury or increased intracranial pressure
- Kidney problems
- Pregnancy and breastfeeding
- Other medication interactions
- Acetaminophen-containing products
- Stomach blockage or intestine problems
- Urination problems
- Sleep apnea
- Problems with your thyroid, pancreas, or gallbladder
Vicodin causes breathing problems, especially in severely ill older adults and those who are malnourished. It is not advised to consume it if the patient is allergic to acetaminophen and hydrocodone, and it is not recommended to use it if the patient has had alcohol or any other sedative or narcotic medications. The drug has major interactions with MAO inhibitors, and it is suggested not to consume the drug to avoid complications.
Serotonin syndrome is a serious condition that is caused by the interaction with hydrocodone. Kidney impairment may affect medication handling and requires appropriate medical consideration. Previous opioid misuse, addiction, or other substance-use problems should be discussed before treatment. Liver impairment can increase the risk associated with acetaminophen.
Application/Consumption
It is taken orally, and it is advised to use only prescription medication and follow the advice given by the respective consultant. No two individuals are advised to consume the same dose even if the symptoms are the same, as it is an individualized dose according to one’s pain severity, previous opioid exposure, response to treatment, and the occurrence of adverse effects; if taken, a doctor's consultation is recommended.
Current generic products are available in combinations such as 5 mg/325 mg, 7.5 mg/325 mg, and 10 mg/325 mg of hydrocodone bitartrate/acetaminophen. It is directed not to use more than the prescribed dosage or combine it with other medications that contain acetaminophen unless consulted with a doctor. According to FDA guidelines, it increases the risk of overdosing if the opioid dose is increased; immediate-release opioids are not recommended for prolonged use unless the severe pain continues and alternatives remain inadequate, but consultation is recommended.
Drowsiness, dizziness, and impaired judgment are major causes of hydrocodone, which is why it is not recommended for patients to drive or operate machinery. It should be stored as directed and out of reach of children.
Dosing information
- The dosage of hydrocodone/acetaminophen depends on the strength prescribed and the individual's pain and opioid tolerance.
- The acetaminophen component is particularly important when calculating the total daily amount because other prescription or nonprescription medicines may also contain acetaminophen.
- Patients who are already receiving other opioids require individualized conversion rather than simply substituting an equivalent number of tablets.
Uses
Vicodin and generic hydrocodone/acetaminophen are primarily used for:
- For relieving severe and moderate pain
- Short-term management of acute pain when an opioid analgesic is considered necessary.
- Pain management when alternative treatments are inadequate.
- Additional pain relief through the combined action of hydrocodone and acetaminophen.
FDA information describes hydrocodone and acetaminophen products as prescription opioid analgesics for pain severe enough to require an opioid when alternative treatments are inadequate.
Vicodin side effects
Common side effects include drowsiness, dizziness, nausea, vomiting, constipation, abdominal discomfort, headache, and sedation. Hydrocodone can also impair coordination and judgment. Respiratory depression is a potentially serious opioid-related adverse effect.
More serious problems include dangerously slow or difficult breathing, extreme sleepiness, severe hypotension, confusion, allergic reactions, and overdose. The risk is increased when hydrocodone is combined with alcohol, benzodiazepines, sleep medicines, or other CNS depressants. Patients experiencing very slow or difficult breathing, inability to stay awake, or suspected overdose require immediate emergency medical attention.
Acetaminophen-related hepatotoxicity is another major concern. Signs of significant liver injury include nausea, vomiting, abdominal pain, unusual sweating, weakness, jaundice, dark urine, or confusion. Patients should seek medical attention if they suspect that they have taken too much acetaminophen, even if they initially feel well.
Longer opioid exposure can lead to physical dependence and withdrawal symptoms if treatment is stopped abruptly. Opioids can also cause opioid-induced hyperalgesia, in which pain sensitivity may increase during opioid treatment. FDA's more recent opioid-labeling updates specifically added information about this risk.
Hydrocodone also has clinically important interactions with medicines that affect CYP3A4, an enzyme involved in hydrocodone metabolism. CYP3A4 inhibitors can increase hydrocodone exposure and potentially increase sedation and respiratory depression, while inducers can
reduce exposure and potentially affect pain control. Patients should therefore provide their complete medication list to their healthcare professional before starting the treatment.
Because the medicine contains acetaminophen, interactions and other therapy involving other acetaminophen products should also be considered. Regular monitoring is particularly important for patients receiving prolonged courses, those with liver or respiratory conditions, and people taking other sedating medicines.
Key insight:
In January 2025, Vertex Pharmaceuticals launched Journavx (suzetrigine). It is the first new class of non-opioid acute pain medication approved by the FDA in over 25 years, designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. https://www.cleveland.com/news/2025/01/fda-approves-painkiller-designed-to-eliminate-the-risk-of-addiction-associated-with-opioids.html
Request Consultation